A New Security Testing Method and Its Application to the Secure Xenix Kernel

1987 ◽  
Vol SE-13 (2) ◽  
pp. 169-183 ◽  
Author(s):  
V.D. Gligor ◽  
C.S. Chandersekaran ◽  
Wen-Der Jiang ◽  
A. Johri ◽  
G.L. Luckenbaugh ◽  
...  
Author(s):  
V.D. Gligor ◽  
C.S. Chandersekaran ◽  
W. Cheng ◽  
W.D. Jiang ◽  
A. Johri ◽  
...  

2014 ◽  
Vol 1049-1050 ◽  
pp. 1972-1976
Author(s):  
Cheng He ◽  
Yan Fei Liu

Compared with traditional web sites, there are some new features on modern web applications, as follows: dynamic functionalities, diverse representation, uncertainty for running performance, innovative data handling and data transferring mechanism, vulnerability Subsequently, the problems in testing web application are discussed from functional testing , reliability testing and security testing. At last, in order to solve these problems,new testing methods are proposed, which are systematic web application testing method,random test methods, reliability testing methods and security testing methods.


2014 ◽  
Vol 2014 ◽  
pp. 1-10 ◽  
Author(s):  
Yu Long Fu ◽  
Xiao Long Xin

The security of protocol implementation is important and hard to be verified. Since the penetration testing is usually based on the experience of the security tester and the specific protocol specifications, a formal and automatic verification method is always required. In this paper, we propose an extended model of IOLTS to describe the legal roles and intruders of security protocol implementations, and then combine them together to generate the suitable test cases to verify the security of protocol implementation.


2009 ◽  
Vol 29 (03) ◽  
pp. 285-290 ◽  
Author(s):  
K. E. Guyer

SummaryAntiplatelet therapy has demonstrated significant clinical benefit in the treatment of acute coronary syndrome. However, as with any treatment strategy it has been unable to prevent all cardiovascular events. This is far from surprising when considering the complexity of arterial thrombosis and more specifically platelet physiology. This lack of treatment success has provoked the introduction of various diagnostic tests and testing platforms with the intent of guiding and optimizing clinical treatment. Such tests have resulted in the generation of clinical data that suggest suboptimal response to antiplatelet agents such as aspirin and clopidogrel.In the case of both aspirin and clopidogrel, this suboptimal response has been termed resistance. Drug resistance would imply a lack of pharmacological response that has not been specifically investigated in many of the clinical studies performed to date. Rather, the term resistance has been used to describe various facets of platelet activation and aggregation relative to the testing method. Many of these measured parameters are not addressed in the therapeutic intent of the antiplatelet drug in question.


Sign in / Sign up

Export Citation Format

Share Document